CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
DiscussionCompARE is designed to be efficient and cost-effective in response to new data, emerging new treatments or difficulties, with the aim of bringing new treatment options for these patients.Trial registrationISRCTNISRCTN41478539. Registered on 29 April 2015
Source: Trials - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Research | Smokers | Study | Toxicology